Cancer Diagnostic Tools Startup Wins Michigan Innovation Competition

Cancer Diagnostic Tools Startup Wins Michigan Innovation Competition


Armune BioScience won $500,000 on Saturday November 11th, 2010 in the 2010 Accelerate Michigan Innovation Competition at the University of Michigan in Ann Arbor. Armune BioScience beat 279 other competitors for the grand prize for a project that makes detection and treatment of prostate cancer easier and less invasive by studying the body’s immune response to cancer cells.

Armune BioScience was formed to develop and commercialize high value, protein signature-based diagnostic tests for prostate, lung and breast cancers that will allow physicians and patients to make better treatment decisions.

A group of judges composed of private equity and venture capital professionals and investment bankers determined the winners, based on written evaluations and company presentations. The international competition was designed to promote entrepreneurship in Michigan and attracted entries from 13 states around the country as well as Canada, Switzerland and South Africa. The contest is sponsored by the New Economy Initiative for Southeast Michigan and is run by the economic development group Ann Arbor SPARK on behalf of the Business Accelerator Network for Southeast Michigan.